Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bristol-Myers Squibb
Pharmacokinetics and Safety in Healthy Subjects
Age
18–49
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Healthy male and female subjects aged 18 to 49 years
Females who are not of childbearing potential, pregnant or breastfeeding
Subject Body Mass Index (BMI) of 18 to 32 kg/m²
You may not be if
Women of child bearing potential
Male subjects who have sex with women who are unwilling to agree to practice male barrier contraception during study participation and for a least 12 weeks following dosing
Any significant acute or chronic medical illness
Evidence of organ dysfunction or any clinically significant deviation from normal in physical examination, vital signs, ECG or clinical laboratory determinations
